HK Stock MarketDetailed Quotes

01858 CHUNLI MEDICAL

Watchlist

8.640
-0.340-3.79%

Market Closed Dec 13 16:08 CST

3.31BMarket Cap18.86P/E (TTM)

CHUNLI MEDICAL Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Turnover

-35.84%508.28M

-29.70%380.13M

-9.95%221.85M

0.58%1.21B

4.24%792.16M

-5.37%540.71M

-4.18%246.36M

8.43%1.2B

5.79%759.96M

18.39%571.39M

Operating income

-35.84%508.28M

-29.70%380.13M

-9.95%221.85M

0.58%1.21B

4.24%792.16M

-5.37%540.71M

-4.18%246.36M

8.43%1.2B

5.79%759.96M

18.39%571.39M

Operating expenses

32.85%-156.04M

27.50%-108.25M

25.51%-58.04M

-15.47%-332.64M

-17.08%-232.37M

-2.55%-149.3M

-55.17%-77.92M

-13.60%-288.08M

-18.58%-198.48M

-28.42%-145.59M

Gross profit

-37.08%352.24M

-30.54%271.88M

-2.75%163.81M

-4.12%875.89M

-0.30%559.78M

-8.08%391.41M

-18.59%168.44M

6.90%913.53M

1.90%561.49M

15.31%425.8M

Selling expenses

30.07%-163.46M

33.20%-111.48M

2.80%-63.15M

2.13%-383.14M

-1.56%-233.75M

-7.66%-166.89M

18.69%-64.97M

-14.45%-391.47M

1.55%-230.17M

-8.68%-155.01M

Administrative expenses

-8.46%-31.36M

-12.41%-21.31M

-6.69%-7.52M

-14.50%-44.47M

-17.15%-28.91M

-22.59%-18.96M

-17.28%-7.05M

-26.63%-38.84M

-15.36%-24.68M

-13.54%-15.46M

Research and development expenses

13.13%-99.68M

9.27%-67.66M

-5.17%-34.99M

3.02%-157.45M

-9.26%-114.74M

-3.16%-74.57M

-0.47%-33.27M

-54.84%-162.34M

-61.11%-105.01M

-111.19%-72.29M

Profit from asset sales

7,237.14%39.21K

--39.21K

----

-84.57%3.9K

-102.17%-549.43

----

70.33%25.31K

208.84%25.31K

Revaluation surplus

-14.03%6.08M

6.57%4.67M

-31.73%1.38M

1.27%9.61M

8.14%7.07M

10.60%4.38M

19.29%2.02M

--9.49M

--6.54M

--3.96M

-Changes in the fair value of other assets

-14.03%6.08M

6.57%4.67M

-31.73%1.38M

1.27%9.61M

8.14%7.07M

10.60%4.38M

19.29%2.02M

--9.49M

--6.54M

--3.96M

Impairment and provision

-43.49%-16.47M

7.86%-11.02M

31.10%-5.48M

17.33%-25.02M

14.50%-11.48M

28.70%-11.96M

-58.09%-7.95M

-10.91%-30.27M

-4.13%-13.43M

-63.90%-16.78M

-Other impairment is provision

-43.49%-16.47M

7.86%-11.02M

31.10%-5.48M

17.33%-25.02M

14.50%-11.48M

28.70%-11.96M

-58.09%-7.95M

-10.91%-30.27M

-4.13%-13.43M

-63.90%-16.78M

Special items of operating profit

11.86%16.99M

-11.25%12.5M

10.49%6.02M

13.14%24.82M

-47.15%15.19M

128.98%14.08M

567.34%5.45M

25.68%21.94M

85.95%28.73M

-54.22%6.15M

Operating profit

-68.86%58.37M

-45.10%73.27M

-4.75%58.24M

-6.26%289.39M

-12.73%187.42M

-20.96%133.47M

-26.22%61.14M

-13.75%308.73M

-5.28%214.75M

-4.64%168.86M

Financing cost

-16.81%7.09M

80.47%9.01M

-9.55%1.08M

-17.81%16.58M

-48.62%8.52M

-13.57%4.99M

-14.82%1.2M

109.24%20.17M

94.68%16.58M

8.00%5.78M

Special items of earning before tax

1,530.27%713.98K

909.91%783.77K

819.68%839.1K

-100.87%-69.6K

97.78%-49.92K

103.46%77.61K

91.23%-116.59K

3,843.45%7.97M

-1,295.24%-2.25M

-1,126.43%-2.24M

Earning before tax

-66.22%66.16M

-40.04%83.07M

-3.31%60.16M

-9.19%305.91M

-14.49%195.88M

-19.64%138.54M

-24.99%62.23M

-8.30%336.88M

-2.55%229.07M

-5.41%172.4M

Tax

66.53%-5.16M

67.26%-4.11M

20.53%-5.06M

3.68%-28.09M

20.47%-15.4M

18.57%-12.55M

28.73%-6.36M

35.22%-29.16M

37.32%-19.37M

42.26%-15.41M

After-tax profit from continuing operations

-66.20%61.01M

-37.33%78.96M

-1.35%55.11M

-9.72%277.82M

-13.94%180.48M

-19.75%125.99M

-24.53%55.86M

-4.54%307.72M

2.71%209.71M

0.92%156.98M

Earning after tax

-66.20%61.01M

-37.33%78.96M

-1.35%55.11M

-9.72%277.82M

-13.94%180.48M

-19.75%125.99M

-24.53%55.86M

-4.54%307.72M

2.71%209.71M

0.92%156.98M

Minority profit

-0.29%-142.8K

29.05%-65.18K

---92.55K

---5.9K

---142.39K

---91.88K

----

Profit attributable to shareholders

-66.14%61.15M

-37.32%79.03M

-1.18%55.2M

-9.72%277.82M

-13.87%180.62M

-19.69%126.08M

-24.53%55.86M

-4.54%307.72M

2.71%209.71M

0.92%156.98M

Basic earnings per share

-65.96%0.16

-36.36%0.21

-6.67%0.14

-10.00%0.72

-14.55%0.47

-19.51%0.33

-21.05%0.15

-13.98%0.8

-6.78%0.55

-8.89%0.41

Diluted earnings per share

-65.96%0.16

-36.36%0.21

-6.67%0.14

-10.00%0.72

-14.55%0.47

-19.51%0.33

-21.05%0.15

-13.98%0.8

-6.78%0.55

-8.89%0.41

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified Opinion

Auditor

Daxin Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Turnover	-35.84%508.28M	-29.70%380.13M	-9.95%221.85M	0.58%1.21B	4.24%792.16M	-5.37%540.71M	-4.18%246.36M	8.43%1.2B	5.79%759.96M	18.39%571.39M
Operating income	-35.84%508.28M	-29.70%380.13M	-9.95%221.85M	0.58%1.21B	4.24%792.16M	-5.37%540.71M	-4.18%246.36M	8.43%1.2B	5.79%759.96M	18.39%571.39M
Operating expenses	32.85%-156.04M	27.50%-108.25M	25.51%-58.04M	-15.47%-332.64M	-17.08%-232.37M	-2.55%-149.3M	-55.17%-77.92M	-13.60%-288.08M	-18.58%-198.48M	-28.42%-145.59M
Gross profit	-37.08%352.24M	-30.54%271.88M	-2.75%163.81M	-4.12%875.89M	-0.30%559.78M	-8.08%391.41M	-18.59%168.44M	6.90%913.53M	1.90%561.49M	15.31%425.8M
Selling expenses	30.07%-163.46M	33.20%-111.48M	2.80%-63.15M	2.13%-383.14M	-1.56%-233.75M	-7.66%-166.89M	18.69%-64.97M	-14.45%-391.47M	1.55%-230.17M	-8.68%-155.01M
Administrative expenses	-8.46%-31.36M	-12.41%-21.31M	-6.69%-7.52M	-14.50%-44.47M	-17.15%-28.91M	-22.59%-18.96M	-17.28%-7.05M	-26.63%-38.84M	-15.36%-24.68M	-13.54%-15.46M
Research and development expenses	13.13%-99.68M	9.27%-67.66M	-5.17%-34.99M	3.02%-157.45M	-9.26%-114.74M	-3.16%-74.57M	-0.47%-33.27M	-54.84%-162.34M	-61.11%-105.01M	-111.19%-72.29M
Profit from asset sales	7,237.14%39.21K	--39.21K	----	-84.57%3.9K	-102.17%-549.43	----	----	70.33%25.31K	70.33%25.31K	208.84%25.31K
Revaluation surplus	-14.03%6.08M	6.57%4.67M	-31.73%1.38M	1.27%9.61M	8.14%7.07M	10.60%4.38M	19.29%2.02M	--9.49M	--6.54M	--3.96M
-Changes in the fair value of other assets	-14.03%6.08M	6.57%4.67M	-31.73%1.38M	1.27%9.61M	8.14%7.07M	10.60%4.38M	19.29%2.02M	--9.49M	--6.54M	--3.96M
Impairment and provision	-43.49%-16.47M	7.86%-11.02M	31.10%-5.48M	17.33%-25.02M	14.50%-11.48M	28.70%-11.96M	-58.09%-7.95M	-10.91%-30.27M	-4.13%-13.43M	-63.90%-16.78M
-Other impairment is provision	-43.49%-16.47M	7.86%-11.02M	31.10%-5.48M	17.33%-25.02M	14.50%-11.48M	28.70%-11.96M	-58.09%-7.95M	-10.91%-30.27M	-4.13%-13.43M	-63.90%-16.78M
Special items of operating profit	11.86%16.99M	-11.25%12.5M	10.49%6.02M	13.14%24.82M	-47.15%15.19M	128.98%14.08M	567.34%5.45M	25.68%21.94M	85.95%28.73M	-54.22%6.15M
Operating profit	-68.86%58.37M	-45.10%73.27M	-4.75%58.24M	-6.26%289.39M	-12.73%187.42M	-20.96%133.47M	-26.22%61.14M	-13.75%308.73M	-5.28%214.75M	-4.64%168.86M
Financing cost	-16.81%7.09M	80.47%9.01M	-9.55%1.08M	-17.81%16.58M	-48.62%8.52M	-13.57%4.99M	-14.82%1.2M	109.24%20.17M	94.68%16.58M	8.00%5.78M
Special items of earning before tax	1,530.27%713.98K	909.91%783.77K	819.68%839.1K	-100.87%-69.6K	97.78%-49.92K	103.46%77.61K	91.23%-116.59K	3,843.45%7.97M	-1,295.24%-2.25M	-1,126.43%-2.24M
Earning before tax	-66.22%66.16M	-40.04%83.07M	-3.31%60.16M	-9.19%305.91M	-14.49%195.88M	-19.64%138.54M	-24.99%62.23M	-8.30%336.88M	-2.55%229.07M	-5.41%172.4M
Tax	66.53%-5.16M	67.26%-4.11M	20.53%-5.06M	3.68%-28.09M	20.47%-15.4M	18.57%-12.55M	28.73%-6.36M	35.22%-29.16M	37.32%-19.37M	42.26%-15.41M
After-tax profit from continuing operations	-66.20%61.01M	-37.33%78.96M	-1.35%55.11M	-9.72%277.82M	-13.94%180.48M	-19.75%125.99M	-24.53%55.86M	-4.54%307.72M	2.71%209.71M	0.92%156.98M
Earning after tax	-66.20%61.01M	-37.33%78.96M	-1.35%55.11M	-9.72%277.82M	-13.94%180.48M	-19.75%125.99M	-24.53%55.86M	-4.54%307.72M	2.71%209.71M	0.92%156.98M
Minority profit	-0.29%-142.8K	29.05%-65.18K	---92.55K	---5.9K	---142.39K	---91.88K	----	----	----	----
Profit attributable to shareholders	-66.14%61.15M	-37.32%79.03M	-1.18%55.2M	-9.72%277.82M	-13.87%180.62M	-19.69%126.08M	-24.53%55.86M	-4.54%307.72M	2.71%209.71M	0.92%156.98M
Basic earnings per share	-65.96%0.16	-36.36%0.21	-6.67%0.14	-10.00%0.72	-14.55%0.47	-19.51%0.33	-21.05%0.15	-13.98%0.8	-6.78%0.55	-8.89%0.41
Diluted earnings per share	-65.96%0.16	-36.36%0.21	-6.67%0.14	-10.00%0.72	-14.55%0.47	-19.51%0.33	-21.05%0.15	-13.98%0.8	-6.78%0.55	-8.89%0.41
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	Unqualified Opinion	--	--
Auditor	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--	--	Daxin Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks